A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CTDs / connective tissue diseases

[Related PubMed/MEDLINE]
Total Number of Papers: 251
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CTDs  (>> Co-occurring Abbreviation)
Long Form:   connective tissue diseases
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion. ADA, CPPE, MPE, PE, PF, TPE, UPPE
2021 A study on echocardiographic findings in hospitalized patients with connective tissue diseases. ---
2021 An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of pulmonary hypertension in patients with connective tissue disease. CTEPH, PAH, PH
2021 Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications. CTD-ILD, ILD
2021 Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases. CPET, PAH
2021 Cholinergic anti-inflammatory pathway and connective tissue diseases. CAP
2021 Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids. PCP, TMP-SMX
2021 Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases. ILD
2021 Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases. ILD
10  2021 Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases. CTD-ILDs, ILDs
11  2021 Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy. IL-22, IL-22R
12  2021 Nailfold Capillaroscopy With USB Digital Microscopy in Connective Tissue Diseases: A Comparative Study of 245 Patients and Healthy Controls. CI, DM, NFC, SLE, SSc, USB
13  2021 Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases. NVC, PAH
14  2021 New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. ACA, ACE-2, ANA, COVID-19, ME, nsp1, SARS-CoV-2
15  2021 Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis. IJDs, RMDs
16  2021 Recognition and Management of Cutaneous Connective Tissue Diseases. ---
17  2021 Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs). CTD, OPN, PAH
18  2021 The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective. AF, aPL, APS
19  2021 The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease. ILD
20  2021 Urinary abnormality in mixed connective tissue disease predicts development of other connective tissue diseases and decrease in renal function. eGFR, MCTD
21  2021 Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases. HRCT, ILD
22  2021 Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic? ---
23  2021 [Interstitial lung disease associated with connective tissue disease]. HRCT, IIM, IIPs, ILD, IPAF, RA, SSc
24  2020 A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays vs. indirect immunofluorescence for initial screening of connective tissue diseases. ANA, CI, CLIA, ELISA, FEIA, IAs, IIF, MIA
25  2020 Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study. aPL, APS, CPRD, RR, SLE
26  2020 Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan. aORs, DMtis, ILD, PM, pSS, RA, SLE, SSc
27  2020 Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis. AIA, CFA, cit, EBV, HCs, IRF5, MAP, mBSA, WT
28  2020 Aryl hydrocarbon receptor signals attenuate lung fibrosis in the bleomycin-induced mouse model for pulmonary fibrosis through increase of regulatory T cells. AhR, BLM, ILD
29  2020 Clinical features and prognosis of nocardiosis in patients with connective tissue diseases. ---
30  2020 Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. IA
31  2020 Clinical significance of minor salivary gland biopsy in patients with idiopathic interstitial pneumonia. IIP, MSGB, pSS, UIP
32  2020 Clinical significance of thyroid hormone and antibodies in patients with idiopathic interstitial pneumonia. ESR, IIP, IPF
33  2020 Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias. IIPs, iNSIP, IPAF, NSIP, OP
34  2020 Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management. AS, CTD-ILD, CTD-ILDs, DAD, DM, ILA, ILD, LIP, MCTD, NSIP, OP, PM, PSS, RA, SLE, SS, UIP
35  2020 Constrictive (Obliterative) Bronchiolitis as Presenting Manifestation of Connective Tissue Diseases. ---
36  2020 Decreased serum ACE2 levels in patients with connective tissue diseases. ACE2, RA, SLE, SS, SSc
37  2020 Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan. PAH, PM/DM, pSS, RA, SLE, SSc
38  2020 Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - A systematic literature review. DM, IIM, PM, SLE
39  2020 FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases. AOSD, FUO
40  2020 Inherited chromosomally integrated human herpesvirus 6 and autoimmune connective tissue diseases. ciHHV-6, HHV-6
41  2020 Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases. DM, EBI3, IL, PM, pSS, RA, SLE, SSc, Th17
42  2020 Interstitial pneumonia with autoimmune features. ANA, ANCA, ILD, IPAF, IPF, NSIP, SSc
43  2020 JAK Inhibitors: Prospects in Connective Tissue Diseases. RA
44  2020 National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease. aOR, APLS, CABG
45  2020 Neurovascular manifestations in connective tissue diseases: The case of Marfan Syndrome. MFS
46  2020 Nonspecific Interstitial Pneumonia. NSIP
47  2020 Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease. ASS, HP, ILD, IPF, UIP
48  2020 Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease. CTD-ILD, FVC, ILD, MMF
49  2020 Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study. CI, HR, IIM, LC, OS, PUMCH, RA, SLE, SS, SSc
50  2020 Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review. ILD
51  2019 A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: Systematic literature review and meta-analysis of diagnostic test accuracy studies. FEIA, IIF, LR
52  2019 Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. AE, fILD, IPF
53  2019 Basic Calcium Phosphate Crystal Periarthritis Involving the Distal Interphalangeal Joints in a Patient with Systemic Lupus Erythematosus. BCP, CPP, CTD, DIP, SLE
54  2019 Computed Tomographic Imaging in Connective Tissue Diseases. ---
55  2019 Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. FVC, HRCT, IIMs, ILD, OLD, PAH, PFTs, RA, SSDs, UIP
56  2019 Degos-Like Lesions In Association With Connective Tissue Diseases: A Report Of Three Cases And Literature Review. SLE
57  2019 Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations. DM, VTE
58  2019 Histology of Pulmonary and Bronchiolar Disorders in Connective Tissue Diseases. ---
59  2019 Interstitial pneumonia with autoimmune features that met the proposed diagnostic criteria for IgG4-related respiratory disease. IgG4, IgG4-RLD, ILD, IPAF, MDD, RA
60  2019 Lung Transplant in Patients with Connective Tissue Diseases. ---
61  2019 Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease. DM/PM, ILD, MAAs, MSAs, PPV
62  2019 Pathological interpretation of connective tissue disease-associated lung diseases. CTD-LDs
63  2019 Practice Patterns of Pneumocystis Pneumonia Prophylaxis in Connective Tissue Diseases: A Survey of Infectious Disease Physicians. ID, PCP
64  2019 Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies. IIM, MAA
65  2019 Thoracic Manifestations of Connective Tissue Diseases. ---
66  2019 Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis. IIM
67  2019 Ultrasound and interstitial lung disease: use and limitations. ILD, TUS
68  2019 Ultrasound as a potential tool for the assessment of interstitial lung disease in rheumatic patients. Where are we now? HRCT, ILD, LUS
69  2019 Ultrasound salivary gland involvement in Sjogren's syndrome vs. other connective tissue diseases: is it autoantibody and gland dependent? SG, SS, US
70  2019 Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. CPGs
71  2018 A better definition of the anti-DFS70 antibody screening by IIF methods. ANA, CIA, IB
72  2018 Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases. APOs, CS, LAC
73  2018 Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians? AAbs
74  2018 Chemerin, Resistin, and Adiponectin in Patients with Connective Tissue Diseases. AUC-ROC, CRP
75  2018 Clinical analysis of 215 consecutive cases with fever of unknown origin: A cohort study. AOSD, FUO, IDs, Mi
76  2018 Comorbid connective tissue diseases and autoantibodies in lymphangioleiomyomatosis: a retrospective cohort study. LAM, SjS
77  2018 Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum. MTX, PCP, RA
78  2018 High Dose Prednisolone Lowers Plasma Glycated Albumin Levels Compared to Actual Glycemic Control: A Retrospective Observational Study. ALB, BMI, CI, CRE, GA, PSL
79  2018 Mixed connective tissue disease: state of the art on clinical practice guidelines. CPGs, MCTD
80  2018 Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre. CPK, IIMs, NAM
81  2018 Overlap syndromes in systemic sclerosis. ACR, dcSSc, lcSSc, OS, SSc
82  2018 Peripheral CD4+ T-cell changes in connective tissue diseases. Th
83  2018 Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review. IPF
84  2018 Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders. ---
85  2018 Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases. MSCT, pSS, SLE
86  2018 Spontaneous Pneumomediastinum in Connective Tissue Diseases. SP
87  2018 State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances. ILD, IPAF
88  2018 The use of ultrasound for assessing interstitial lung involvement in connective tissue diseases. ILD
89  2018 Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. NPV, PAH, SSc, TRV, TTE
90  2018 [2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases]. ILD
91  2017 An analysis of the clinical features of lung cancer in patients with connective tissue diseases. AE, CTD-ILD, ILD, LC
92  2017 Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases. ---
93  2017 Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists. CTD-ILD, ILD
94  2017 Detection of early endothelial damage in patients with Raynaud's phenomenon. CNP, CSP, HS, IL-6, RP, SSc, tPA, vWF
95  2017 Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis. DM, HHV-6
96  2017 Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. ILDs
97  2017 Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy? ANA
98  2017 Mortality trend of inpatients with connective tissue diseases: 2005-2014. IIM, ILD
99  2017 Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis. ANAs, CI, pRp, RP, RR, SE, SSc, ssRp
100  2017 Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented? GPA, OI, PCP